← FDA Drug Approvals (Drugs@FDA)
NELARABINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: DR REDDYS · Approved 2022-12-22
Drug application
- FDA Application #
ANDA216934- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- NELARABINE
- Generic name
- NELARABINE
- Active ingredients
- NELARABINE
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- DR REDDYS
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- First approval
- 2022-12-22
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown